 NEWTON, Mass. , March 9, 2022 PRNewswire -- Karyopharm Therapeutics Inc. Nasdaq: KPTI, a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Companys senior management team will participate in a fireside chat at the Barclays Global Healthcare Conference. 